These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 15142566)

  • 1. DAT/SERT selectivity of flexible GBR 12909 analogs modeled using 3D-QSAR methods.
    Gilbert KM; Boos TL; Dersch CM; Greiner E; Jacobson AE; Lewis D; Matecka D; Prisinzano TE; Zhang Y; Rothman RB; Rice KC; Venanzi CA
    Bioorg Med Chem; 2007 Jan; 15(2):1146-59. PubMed ID: 17127069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chirality Matters: Fine-Tuning of Novel Monoamine Reuptake Inhibitors Selectivity through Manipulation of Stereochemistry.
    Kalaba P; Pacher K; Neill PJ; Dragacevic V; Zehl M; Wackerlig J; Kirchhofer M; Sartori SB; Gstach H; Kouhnavardi S; Fabisikova A; Pillwein M; Monje-Quiroga F; Ebner K; Prado-Roller A; Singewald N; Urban E; Langer T; Pifl C; Lubec J; Leban JJ; Lubec G
    Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chiral Resolution of the Enantiomers of the Slow-Onset Dopamine Reuptake Inhibitor CTDP-32476 and Their Activities.
    Froimowitz M; Taboada R; Poulos ZJ; Rainone DJ; Imler GH; Gardner EL; Kelley CJ
    ACS Omega; 2023 Oct; 8(39):35738-35745. PubMed ID: 37810691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntheses of novel diphenyl piperazine derivatives and their activities as inhibitors of dopamine uptake in the central nervous system.
    Kimura M; Masuda T; Yamada K; Mitani M; Kubota N; Kawakatsu N; Kishii K; Inazu M; Kiuchi Y; Oguchi K; Namiki T
    Bioorg Med Chem; 2003 Apr; 11(8):1621-30. PubMed ID: 12659747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and transporter binding properties of bridged piperazine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909).
    Zhang Y; Rothman RB; Dersch CM; de Costa BR; Jacobson AE; Rice KC
    J Med Chem; 2000 Dec; 43(25):4840-9. PubMed ID: 11123994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel diphenylalkyl piperazine derivatives with high affinities for the dopamine transporter.
    Kimura M; Masuda T; Yamada K; Mitani M; Kubota N; Kawakatsu N; Kishii K; Inazu M; Kiuchi Y; Oguchi K; Namiki T
    Bioorg Med Chem; 2003 Sep; 11(18):3953-63. PubMed ID: 12927856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship studies of highly selective inhibitors of the dopamine transporter: N-benzylpiperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine.
    Greiner E; Prisinzano T; Johnson EM; Dersch CM; Marcus J; Partilla JS; Rothman RB; Jacobson AE; Rice KC
    J Med Chem; 2003 Apr; 46(8):1465-9. PubMed ID: 12672246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of long-acting dopamine transporter ligands as potential cocaine-abuse therapeutic agents: chiral hydroxyl-containing derivatives of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine.
    Hsin LW; Dersch CM; Baumann MH; Stafford D; Glowa JR; Rothman RB; Jacobson AE; Rice KC
    J Med Chem; 2002 Mar; 45(6):1321-9. PubMed ID: 11882001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient asymmetric syntheses, determination of absolute configurations and biological activities of 1-[4,4-bis(4-fluorophenyl)butyl]-4-[2-hydroxy-3-(phenylamino)propyl]piperazine as a novel potent dopamine uptake inhibitor in the central nervous system.
    Kimura M; Masuda T; Yamada K; Mitani M; Kubota N; Kawakatsu N; Kishii K; Inazu M; Kiuchi Y; Oguchi K; Namiki T
    Bioorg Med Chem; 2004 Jun; 12(11):3069-78. PubMed ID: 15142566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine transporter as target for drug development of cocaine dependence medications.
    Dutta AK; Zhang S; Kolhatkar R; Reith ME
    Eur J Pharmacol; 2003 Oct; 479(1-3):93-106. PubMed ID: 14612141
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.